Pfizer Inc.
ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF

Last updated:

Abstract:

This invention provides a polypeptide derived from E. coli or a fragment thereof, including compositions and methods thereof. In one embodiment, the compositions comprise a polypeptide derived from E. coli or a fragment thereof; and modified O-polysaccharide molecules derived from E. coli lipopolysaccharides or conjugates thereof. In a further aspect, the compositions further comprise modified O-polysaccharide molecules derived from Klebsiella pneumoniae or conjugates thereof.

Status:
Application
Type:

Utility

Filling date:

22 Feb 2021

Issue date:

2 Sep 2021